Clinical trial
GW815SF For Chronic Obstructive Pulmonary Disease (Chronic Bronchitis…
NCT00269087 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00269087 |
|---|---|
| Title | GW815SF For Chronic Obstructive Pulmonary Disease (Chronic Bronchitis, Emphysema) |
| Official title | Clinical Evaluation of GW815SF for Chronic Obstructive Pulmonary Disease (Chronic Bronchitis, Emphysema)" A Long-term Treatment Study of GW815SF50/500µg in Chronic Obstructive Pulmonary Disease - |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pulmonary Disease, Chronic Obstructive |
| Intervention type | Drug |
| Interventions | fluticasone propionate/salmeterol combination DISKUS |
| Enrollment | 122 |
| Start date | Jan 28, 2005 |
| Primary completion | Oct 1, 2006 |
| Completion | Oct 25, 2006 |
| First posted | Dec 23, 2005 |
| Last update posted | Feb 1, 2019 |
| Countries | Japan |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: